Communications Biology (Apr 2023)
CRISPR-clear imaging of melanin-rich B16-derived solid tumors
Abstract
Tyrosinase CRISPR knock out in the B16 melanoma cell line eliminates melanin production, with the lack of pigment not affecting tumour engraftment or growth and allowing for 3D imaging after clearing by PACT.